The Leukemia & Lymphoma Society & Walgreens Partner To Support Cancer Patients In Their Communities


lymphonaRYE BROOK, N.Y.
and DEERFIELD, Ill., March 16, 2016 /PRNewswire-USNewswire/ — The Leukemia & Lymphoma Society (LLS) and Walgreen Co. today announced the launch of an innovative collaboration designed to further advance cancer therapies and address the changing treatment model facing patients with blood and other cancers. The collaboration, between LLS and Walgreens Specialty Pharmacy, builds on the heritage of Walgreens in serving its communities, and the 66-year history of LLS, which has invested more than $1 billion in research to advance blood cancer treatments and cures.